Episode 25 - AI Partnership for Prostate Cancer Diagnosis


This episode's guests: David West and Joseph Mossel

This episode we are talking with David West, CEO of Proscia and Joseph Mossel, CEO of IBEX Medical Analytics.

Recently, Proscia, a leading provider of digital and computational pathology solutions, and IBEX Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, announced a strategic partnership to support pathologists in detecting prostate cancer.

In this episode, we will examine how this partnership will work to help pathologists and why it was formed in the first place. We will also discuss some of the technologies used and where this will lead digital pathology in the future.


More About David West

David West is CEO and Founder of Proscia

David West is an entrepreneur and technologist with a background in computational biology. He founded Proscia in 2014, inspired by research at Johns Hopkins Medicine. Under David’s leadership, Proscia has earned recognition as a market category leader, raising a total of $35M in funding to date. David has been recognized by Forbes 30 Under 30, Inc. Magazine as one of the top 50 Global Entrepreneurs Under 25. He has a degree in Biomedical Engineering from Johns Hopkins University.

More About Joseph Mossel

Joseph Mossel is CEO and Co-Founder of Ibex Medical Analytics

Together with Co-Founder and CTO Chaim Linhart, he embarked on a journey to transform cancer diagnosis by empowering pathologists with AI insights that help them improve diagnostic accuracy, efficiency and turnaround times.

His career in the tech industry is spanning more than 20 years, starting off in software development and product management followed with leadership positions in startups, large multinational corporations and non-profits. Joseph has led products from inception all the way to maturity as multi-million dollar businesses.